(Q34800429)

4 August 2017

1 reference

title

Polyol pathway and diabetic peripheral neuropathy (English)

1 reference

4 August 2017

Peter J Oates

1

1 reference

4 August 2017

publication date

1 January 2002

1 reference

International Review of Neurobiology

4 August 2017

published in

1 reference

4 August 2017

volume

50

1 reference

4 August 2017

page(s)

325-392

1 reference

Disruption of aldose reductase gene (Akr1b1) causes defect in urinary concentrating ability and divalent cation homeostasis

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Membrane-bound sorbitol dehydrogenase in human red blood cells. Studies in normal subjects and in enzyme-deficient subjects with congenital cataracts

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Water content, vasoactive intestinal polypeptide and substance P in intact and crushed sciatic nerves of normal and streptozotocin-diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

The Composition of Reducing Sugars in Solution

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Characterization of a novel aldose reductase inhibitor, FR74366, and its effects on diabetic cataract and neuropathy in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

The ENZYME database in 2000

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Crystal structure of the NADP(H)-dependent ketose reductase from Bemisia argentifolii at 2.3 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Mapping of aldose reductase gene sequences to human chromosomes 1, 3, 7, 9, 11, and 13.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Diabetic neuropathy in db/db mice develops independently of changes in ATPase and aldose reductase. A biochemical and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

The metabolism and antiketogenic effects of sorbitol; sorbitol dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

The sorbinil trap: a predicted dead-end complex confirms the mechanism of aldose reductase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

1 reference

7 January 2021

Simple repetitive sequences in the genome: structure and functional significance

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Polyol pathway activation and glutathione redox status in non-insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Status of current clinical trials in diabetic polyneuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Coordinate regulation of organic osmolytes in renal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Regulation of gene expression by hypertonicity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Hypertonicity-induced accumulation of organic osmolytes in papillary interstitial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Purification and properties of sorbitol dehydrogenase from mouse liver.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Statil-sensitive polyol formation in nerve of galactose-fed mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Dissociation between biochemical and functional effects of the aldose reductase inhibitor, ponalrestat, on peripheral nerve in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Metabolic and vascular factors in the pathogenesis of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Reversal of defective peripheral nerve conduction velocity, nutritive endoneurial blood flow, and oxygenation by a novel aldose reductase inhibitor, WAY-121,509, in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Molecular genetic analysis of the human sorbitol dehydrogenase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Identification and characterisation of a sequence related to human sorbitol dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Structural and evolutionary characterization of the human sorbitol dehydrogenase gene duplication

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Oxidative stress and glycemic regulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Aldose reductase in the BB rat: isolation, immunological identification and localization in the retina and peripheral nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Studies of aldose reductase using neuronal cell culture and ligated rat sciatic nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

The distribution of polyol: NADP oxidoreductase in mammalian tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Pathogenesis of diabetic neuropathy--do hyperglycemia and aldose reductase inhibitors affect neuroactive steroid formation in the rat sciatic nerves?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Diabetes complications and their potential prevention: aldose reductase inhibition and other approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Modelling studies of the active site of human sorbitol dehydrogenase: an approach to structure-based inhibitor design of the enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

The Effect of Intensive Diabetes Therapy on the Development and Progression of Neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Pathophysiology and treatment of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Kinetic and structural characterization of the glutathione-binding site of aldose reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Assignment of the sorbitol dehydrogenase locus to human chromosome 15 pter leads to q21

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Tolrestat pharmacokinetics in rat peripheral nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Molecular aspects of functional differences between alcohol and sorbitol dehydrogenases

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Aldose and aldehyde reductases: correlation of molecular modeling and mass spectrometric studies on the binding of inhibitors to the active site

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Nerve conduction and aldose reductase inhibition during 5 years of diabetes or galactosaemia in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Distribution of alcohol and sorbitol dehydrogenases. Assessment of mRNA species in mammalian tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Acetyl-blocked N-terminal structures of sorbitol and aldehyde dehydrogenases

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Peripheral diabetic neuropathy. Current recommendations and future prospects for its prevention and management.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Length rather than a specific allele of dinucleotide repeat in the 5' upstream region of the aldose reductase gene is associated with diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Hyperglycemia, Polyol Metabolism, and Complications of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Sorbitol Pathway: Presence in Nerve and Cord with Substrate Accumulation in Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

The sorbitol pathway. Enzyme localization and content in normal and diabetic nerve and cord.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

The human aldose reductase gene maps to chromosome region 7q35

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Direct measurement of the rate of ring opening of D-glucose by enzyme-catalyzed reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Aldose reductase: model for a new paradigm of enzymic perfection in detoxification catalysts

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Human aldose reductase: rate constants for a mechanism including interconversion of ternary complexes by recombinant wild-type enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Oxidized aldose reductase: in vivo factor not in vitro artifact

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Immunoquantitation of aldose reductase in human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Hyperglycemia increases endothelial superoxide that impairs smooth muscle cell Na+-K+-ATPase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

An anion binding site in human aldose reductase: mechanistic implications for the binding of citrate, cacodylate, and glucose 6-phosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Susceptibility to diabetic neuropathy in patients with insulin dependent diabetes mellitus is associated with a polymorphism at the 5' end of the aldose reductase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

[The mechanism of the transformation of glucose in fructose in the seminal vesicles]

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

1 reference

7 January 2021

Oxidative DNA damage in diabetes mellitus: its association with diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Aldose reductase-deficient mice develop nephrogenic diabetes insipidus

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Polymorphisms of the glucose transporter (GLUT1) gene are associated with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Aldose reductase expression is induced by hyperglycemia in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Sorbitol dehydrogenase genetics in the mouse: a 'null' mutant in a 'European' C57BL strain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

NADH: sensor of blood flow need in brain, muscle, and other tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Z-4 allele upstream of the aldose reductase gene is associated with proliferative retinopathy in Japanese patients with NIDDM, and elevated luciferase gene transcription in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Affinity purification and glucose specificity of aldose reductase from bovine lens.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

The purification and properties of aldose reductase from rat ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Structural organization of the human sorbitol dehydrogenase gene (SORD)

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Sorbitol dehydrogenase. The primary structure of the sheep-liver enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Sorbitol dehydrogenase is a zinc enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Properties of sorbitol dehydrogenase and characterization of a reactive cysteine residue reveal unexpected similarities to alcohol dehydrogenases

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

The aldo-keto reductase (AKR) superfamily: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Spirohydantoin inhibitors of aldose reductase inhibit iron- and copper-catalysed ascorbate oxidation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Histochemical demonstration of the soluble enzyme, ketose reductase (sorbitol dehydrogenase), by utilizing a new fixing solution

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Aldose reductase inhibition improves nerve conduction velocity in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

An aldose reductase intragenic polymorphism associated with diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Zinc coordination in mammalian sorbitol dehydrogenase. Replacement of putative zinc ligands by site-directed mutagenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Sorbitol dehydrogenase: cDNA coding for the rat enzyme. Variations within the alcohol dehydrogenase family independent of quaternary structure and metal content

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Variability within mammalian sorbitol dehydrogenases. The primary structure of the human liver enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Enhanced in situ expression of aldose reductase in peripheral nerve and renal glomeruli in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Effects of 15-month aldose reductase inhibition with fidarestat on the experimental diabetic neuropathy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Effects of aldehyde/aldose reductase inhibition on neuronal metabolism of norepinephrine.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

A thirty year journey in the polyol pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

FACTORS AFFECTING THE FORMATION OF SUGAR ALCOHOLS IN OCULAR LENS

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

An (A-C)n dinucleotide repeat polymorphic marker at the 5' end of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Identification and characterization of multiple osmotic response sequences in the human aldose reductase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Contributions of polyol pathway to oxidative stress in diabetic cataract.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

The human sorbitol dehydrogenase gene: cDNA cloning, sequence determination, and mapping by fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Cloning, Sequencing, and Determination of the Sites of Expression of Mouse Sorbitol Dehydrogenase cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Aberrant mRNA splicing causes sorbitol dehydrogenase deficiency in C57BL/LiA mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Kinetic analysis of rat liver sorbitol dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

The kinetic mechanism of sheep liver sorbitol dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Substrate specificity of sheep liver sorbitol dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Methylglyoxal and the polyol pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Effect of pH on sheep liver sorbitol dehydrogenase steady-state kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Reversible inhibition of sheep liver sorbitol dehydrogenase by the antidiabetogenic drug 2-hydroxymethyl-4-(4-N,N-dimethylaminosulfonyl-1-piperazino) pyrimidine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Diabetic nephropathy is not associated with the dinucleotide repeat polymorphism upstream of the aldose reductase (ALR2) gene but with erythrocyte aldose reductase content in Japanese subjects with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Red blood cell sorbitol as an indicator of polyol pathway activity. Inhibition by sorbinil in insulin-dependent diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Novel substrates and inhibitors of human liver sorbitol dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Purification and characterization of human liver sorbitol dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Sorbitol Dehydrogenase from Bovine Lens: Purification and Properties

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Tissue distribution of mammalian aldose reductase and related enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Polyol dehydrogenases. I. The specificity of rat-liver polyol dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Screening for red blood cell sorbitol dehydrogenase deficiency in patients with diabetes or cataracts

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Improvement of nerve conduction velocity in mutant diabetic mice by aldose reductase inhibitor without affecting nerve myo-inositol content

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Sorbitol accumulation and transmembrane efflux in osmotically stressed JS1 schwannoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor fidarestat leads to improvement of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute str

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

The role of aldose reductase gene in the susceptibility to diabetic nephropathy in Type II (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Aldose reductase gene polymorphisms and susceptibility to diabetic nephropathy in Type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Metabolic and electrophoretic studies of rat liver sorbitol dehydrogenase.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Sorbitol dehydrogenase inhibitors (SDIs): a new potent, enantiomeric SDI, 4-[2-1R-hydroxy-ethyl)-pyrimidin-4-yl]piperazine-1-sulfonic acid dimethylamide

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Aldose reductase (AC)(n) microsatellite polymorphism and diabetic microvascular complications in Caucasian Type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Quantitative determination of human aldose reductase by enzyme-linked immunosorbent assay. Immunoassay of human aldose reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

[Aldose reductase in the polyol pathway: a potential target for the therapeutic intervention of diabetic complications]

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Aldose reductase inhibitors: therapeutic implications for diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Polyol-pathway enzymes of human brain. Partial purification and properties of sorbitol dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

(AC)23 [Z-2] polymorphism of the aldose reductase gene and fast progression of retinopathy in Chilean type 2 diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Localization of aldose reductase and sorbitol dehydrogenase in the nervous system of normal and diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Chromosome 7q35 and susceptibility to diabetic microvascular complications

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Glycemic control is related to the morphological severity of diabetic sensorimotor polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

A super-family of medium-chain dehydrogenases/reductases (MDR). Sub-lines including zeta-crystallin, alcohol and polyol dehydrogenases, quinone oxidoreductase enoyl reductases, VAT-1 and other proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

A potential role for aldose reductase in steroid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Aldose reductase inhibitors: the end of an era or the need for different trial designs?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Regulation of myelination: Schwann cell transition from a myelin-maintaining state to a quiescent state after permanent nerve transection

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Fine-structural localization of aldose reductase and ouabain-sensitive, K(+)-dependent p-nitro-phenylphosphatase in rat peripheral nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Aldehyde reductase: the role of C-terminal residues in defining substrate and cofactor specificities

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Aldose and aldehyde reductases from human kidney cortex and medulla

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Absence of the sorbitol pathway in epidermis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Novel NADPH-binding domain revealed by the crystal structure of aldose reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

The biology of the receptor for advanced glycation end products and its ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Inhibition of sorbitol dehydrogenase exacerbates autonomic neuropathy in rats with streptozotocin-induced diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Effect of sorbitol dehydrogenase inhibition on experimental diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Z-2 Microsatellite Allele Is Linked to Increased Expression of the Aldose Reductase Gene in Diabetic Nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

The effects of zenarestat, an aldose reductase inhibitor, on peripheral neuropathy in Zucker diabetic fatty rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Polyol dehydrogenases. 4. Crystallization of the L-iditol dehydrogenase of sheep liver

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Pharmacological properties of fidarestat, a potent aldose reductase inhibitor, clarified by using sorbitol in human and rat erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Formation of sorbitol 6-phosphate by bovine and human lens aldose reductase, sorbitol dehydrogenase and sorbitol kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Aldose and aldehyde reductases in human tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Free sugars in alloxan diabetic rat nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Peripheral nerve structure and function in long-term galactosemic dogs: morphometric and electron microscopic analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Diabetic neuropathy--a continuing enigma

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Characterization of polyol pathway in Schwann cells isolated from adult rat sciatic nerves

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Identification of fructose 3-phosphate in the lens of diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Identity of a major 3-deoxyglucosone-reducing enzyme with aldehyde reductase in rat liver established by amino acid sequencing and cDNA expression

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Aldose reductase inhibitors and diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Mitogen-activated protein kinases as glucose transducers for diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Biochemistry of the acyclic polyols

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

A 'specificity' pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Sorbitol dehydrogenase deficiency in several pig tissues: potential implications for studies of experimental diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Red blood cell sorbitol dehydrogenase deficiency in a family with cataracts

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Diabetic neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Sorbitol dehydrogenase. Full-length cDNA sequencing reveals a mRNA coding for a protein containing an additional 42 amino acids at the N-terminal end.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Interactions of oxidants with vascular signaling systems

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Galactosemic neuropathy in transgenic mice for human aldose reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Differential effects of near-normoglycaemia for 4 years on somatic nerve dysfunction and heart rate variation in type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Diabetic neuropathies: features and mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Glycation and inactivation of sorbitol dehydrogenase in normal and diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

Crystal structure of sorbitol dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

A potent aldose reductase inhibitor, (2S,4S)-6-fluoro-2', 5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide (Fidarestat): its absolute configuration and interactions with the aldose reductase by X-ray crystallography

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2950082-9

7 January 2021

10.1016/S0074-7742(02)50082-9

Identifiers

DOI

1 reference

4 August 2017

1 reference